Interleukin-6 targeting therapy in familial Mediterranean fever

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):150-1. Epub 2013 Sep 9.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Cytoskeletal Proteins / genetics
  • DNA Mutational Analysis
  • Familial Mediterranean Fever / blood
  • Familial Mediterranean Fever / diagnosis
  • Familial Mediterranean Fever / drug therapy*
  • Familial Mediterranean Fever / genetics
  • Familial Mediterranean Fever / immunology
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Molecular Targeted Therapy*
  • Mutation
  • Phenotype
  • Pyrin
  • Receptors, Interleukin-6 / antagonists & inhibitors*
  • Receptors, Interleukin-6 / blood
  • Treatment Outcome
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • Cytoskeletal Proteins
  • Immunosuppressive Agents
  • MEFV protein, human
  • Pyrin
  • Receptors, Interleukin-6
  • tocilizumab